デフォルト表紙
市場調査レポート
商品コード
1435392

遺伝子編集の世界市場レポート 2024

Gene Editing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
遺伝子編集の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

遺伝子編集の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には18.4%の年間複合成長率(CAGR)で171億9,000万米ドルに成長すると予想されます。予測期間中、遺伝子編集は治療薬、精度の向上、商業用途での成長に向けて準備が整っています。主な動向には、高度な編集技術、塩基編集のイノベーション、創薬のための疾患モデリングなどがあります。

遺伝子編集市場は、感染症の蔓延により大幅な成長を遂げており、感染症の検出と治療における遺伝子編集技術の重要性が浮き彫りになっています。これらの技術は、細菌、ウイルス、真菌、寄生虫などのさまざまな微生物によって引き起こされるHIVなどの病気を特定するのに役立ちます。 遺伝子編集の重要な要素である遺伝子治療は、感染性病原体の複製を細胞外レベルで妨げることにより、感染症に対処する上で極めて重要な役割を果たします。生物の細胞への新しい遺伝物質のイントロダクションは、疾患治療の大幅な進歩を意味し、遺伝子編集市場全体の拡大に貢献します。たとえば、UNAIDSは、2023年 7月の時点で、世界のHIV感染者数は3,900万人であると報告しています。これは、その数字が3,770万人だった2020年から3.17%増加したことを反映しています。

世界の遺伝子編集市場は、遺伝性疾患の発生率の増加により成長すると予想されています。遺伝的障害は、遺伝的または自然発生的に発生する、個人のDNAの異常または突然変異によって生じます。これらの障害は、出生時に存在するか、またはその後に発症するさまざまな健康上の問題を引き起こす可能性があります。 遺伝子編集は、鎌状赤血球症、ハンチントン病、Bサラセミア、嚢胞性線維症、アルツハイマー病、パーキンソン病などの重篤な遺伝病に対処する上で大きな可能性をもたらします。たとえば、国立医学図書館(NLM)は、2023年に65歳以上のアメリカ人がアルツハイマー型認知症(AD)を患っていると推計 670万人になると報告しています。医学の進歩が介入しない限り、有病率は2060年までに1,380万人に増加すると予測されています。遺伝的疾患は増加傾向にあり、遺伝子編集テクノロジーの応用が市場の成長を促進すると予想されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の遺伝子編集市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • CRISPR
  • TALEN
  • ZFN
  • 世界の遺伝子編集市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 動物遺伝子工学
  • 植物遺伝子工学
  • 細胞株工学
  • 世界の遺伝子編集市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • バイオテクノロジー
  • 医薬品
  • 受託研究機構

第7章 地域および国の分析

  • 世界の遺伝子編集市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の遺伝子編集市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 遺伝子編集市場の競合情勢
  • 遺伝子編集市場の企業プロファイル
    • AstraZeneca plc
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare Life Sciences
    • Agilent Technologies Inc.

第31章 その他の大手および革新的な企業

  • Lonza Group AG
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • CRISPR Therapeutics
  • Sigma-Aldrich Corporation
  • Promega Corporation
  • GenScript USA Inc.
  • Integrated DNA Technologies Inc.
  • Intellia Therapeutics Inc.
  • DNA Script Inc.
  • Juno Therapeutics Inc.
  • Dharmacon Inc.
  • Precision Biosciences Inc.
  • Editas Medicine Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r15110

Gene editing refers to the innovative technology enabling precise changes in the genetic code at specific locations within a genome. This cutting-edge process involves manipulating genetic material in various fields such as cell line engineering, animal genetic engineering, and plant genetic engineering.

The primary gene editing technologies include CRISPR, TALEN, and ZFN. CRISPR, a groundbreaking method, empowers geneticists and medical researchers to edit sections of the genome by altering, inserting, or removing DNA sequences accurately. These technologies find applications across biotechnology, pharmaceuticals, and contract research organizations, serving purposes in animal genetic engineering, plant genetic engineering, and cell line engineering.

The gene editing market research report is one of a series of new reports from The Business Research Company that provides gene editing market statistics, including gene editing industry global market size, regional shares, competitors with a gene editing market share, detailed gene editing market segments, market trends and opportunities, and any further data you may need to thrive in the gene editing industry. This gene editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene editing market size has grown rapidly in recent years. It will grow from $7.45 billion in 2023 to $8.76 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The historic growth can be attributed to the discovery of CRISPR-Cas9, advancements in genetic sequencing, significant medical breakthroughs, increased funding for scientific research, and the burgeoning growth of the biotechnology industry.

The gene editing market size is expected to see rapid growth in the next few years. It will grow to $17.19 billion in 2028 at a compound annual growth rate (CAGR) of 18.4%. In the forecast period, gene editing is poised for growth in therapeutics, precision improvements, and commercial applications. Major trends include advanced editing techniques, base editing innovations, and disease modeling for drug discovery.

The gene editing market is experiencing substantial growth due to the rising prevalence of communicable diseases, underscoring the significance of gene editing techniques in their detection and treatment. These techniques are instrumental in identifying diseases such as HIV, caused by various microorganisms such as bacteria, viruses, fungi, and parasites. Gene therapy, a crucial component of gene editing, plays a pivotal role in addressing infectious diseases by impeding the replication of the infectious agent at the extracellular level. The introduction of new genetic material into the cells of living organisms represents a significant advancement in disease treatment, contributing to the overall expansion of the gene editing market. For example, as of July 2023, UNAIDS reported a global population of 39 million people living with HIV, reflecting a 3.17% increase from 2020 when the figure stood at 37.7 million.

The global gene editing market is expected to witness growth due to the rising incidence of genetic disorders. Genetic disorders result from abnormalities or mutations in an individual's DNA, either inherited or occurring spontaneously. These disorders can lead to various health issues, either present at birth or developing later in life. Gene editing offers substantial potential in addressing severe genetic diseases such as sickle cell disease, Huntington's disease, B-thalassemia, cystic fibrosis, Alzheimer's, and Parkinson's. For example, the National Library of Medicine (NLM) reported an estimated 6.7 million Americans aged 65 and older living with Alzheimer's dementia (AD) in 2023. The prevalence is projected to increase to 13.8 million by 2060 unless medical breakthroughs intervene. Genetic disorders are on the rise, and the application of gene editing technologies is expected to drive market growth.

Infectious diseases continue to pose a significant threat globally, causing more than 17 million deaths annually, as reported by the World Health Organization (WHO). Public sentiment reflects the growing acceptance of gene editing for the treatment of incurable, hereditary diseases, with 71% of surveyed adults in the US expressing support for its use, according to the AP-NORC survey. Additionally, 67% of Americans endorse gene editing for disease prevention, including conditions such as cancer. This positive perception underscores the potential of gene editing technologies in addressing various health challenges and contributing to market growth.

Major companies are introducing innovative technologies, such as a technique based on special cell-penetrating peptides, which offers advantages over existing methods. In April 2023, Penn Medicine, a prominent US-based multi-hospital health system, discovered that protein fragments used by certain viruses to enter cells could also facilitate the efficient and low-toxicity delivery of CRISPR-Cas gene editing molecules into cells and their DNA-containing nuclei. This breakthrough holds potential for developing advanced cell therapies for diseases such as cancer. The technique is particularly promising for modifying T cells and other patient-derived cells for applications such as CAR T (chimeric antigen receptor T cell) therapy, a specialized immunotherapy for cancer treatment. This new genetic engineering approach promises improvements in speed, efficiency, and reduced cellular toxicity compared to current methods.

The emergence of advanced genome editing techniques stands out as a major trend in the gene editing market. These techniques, characterized by their cost-effectiveness, find applications in diverse fields, including agriculture to enhance the food supply, rectifying specific genetic mutations in the human genome, and preventing the spread of diseases. One notable genome editing technique is CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats), known for its role as molecular scissors that make precise cuts in DNA at specific locations to create space for incorporating new genetic material. CRISPR-Cas9 offers advantages in terms of speed, cost-efficiency, accuracy, and overall effectiveness compared to other existing genome editing methods. Companies such as Crispr Therapeutics (CRSP), Intellia Therapeutics (NTLA), and Editas Medicine are actively investing in CRISPR technology, reflecting the significant impact and potential of this cutting-edge gene editing approach.

In June 2021, PerkinElmer, a U.S.-based company specializing in diagnostics and life sciences, acquired SIRION Biotech for an undisclosed sum. This strategic acquisition aimed to enhance PerkinElmer's capabilities in gene therapy and viral vector technologies, critical for the development of gene therapies across various diseases. The move also positioned PerkinElmer as a key provider of gene delivery technologies, enabling it to meet the increasing demand for gene therapies more effectively. SIRION Biotech, the acquired company, is based in Germany and is known for its expertise in viral vector and gene delivery therapy.

Major companies operating in the gene editing market report are AstraZeneca PLC, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Sigma-Aldrich Corporation, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Juno Therapeutics Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group PLC, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

North America was the largest region in the gene editing market in 2023. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gene editing market includes revenue earned by zinc-finger nucleases (ZFNs) and homing endonucleases or meganucleases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Editing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: CRISPR; TALEN; ZFN
  • 2) By Application: Animal Genetic Engineering; Plant Genetic Engineering; Cell Line Engineering
  • 3) By End Users: Biotechnology; Pharmaceutical; Contract Research Organization
  • Companies Mentioned: AstraZeneca plc; Thermo Fisher Scientific Inc.; Merck KGaA; GE Healthcare Life Sciences; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Editing Market Characteristics

3. Gene Editing Market Trends And Strategies

4. Gene Editing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Gene Editing Market Size and Growth

  • 5.1. Global Gene Editing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gene Editing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gene Editing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gene Editing Market Segmentation

  • 6.1. Global Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • CRISPR
  • TALEN
  • ZFN
  • 6.2. Global Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Cell Line Engineering
  • 6.3. Global Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biotechnology
  • Pharmaceutical
  • Contract Research Organization

7. Gene Editing Market Regional And Country Analysis

  • 7.1. Global Gene Editing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gene Editing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gene Editing Market

  • 8.1. Asia-Pacific Gene Editing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gene Editing Market

  • 9.1. China Gene Editing Market Overview
  • 9.2. China Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gene Editing Market

  • 10.1. India Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gene Editing Market

  • 11.1. Japan Gene Editing Market Overview
  • 11.2. Japan Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gene Editing Market

  • 12.1. Australia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gene Editing Market

  • 13.1. Indonesia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gene Editing Market

  • 14.1. South Korea Gene Editing Market Overview
  • 14.2. South Korea Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gene Editing Market

  • 15.1. Western Europe Gene Editing Market Overview
  • 15.2. Western Europe Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gene Editing Market

  • 16.1. UK Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gene Editing Market

  • 17.1. Germany Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gene Editing Market

  • 18.1. France Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gene Editing Market

  • 19.1. Italy Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gene Editing Market

  • 20.1. Spain Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gene Editing Market

  • 21.1. Eastern Europe Gene Editing Market Overview
  • 21.2. Eastern Europe Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gene Editing Market

  • 22.1. Russia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gene Editing Market

  • 23.1. North America Gene Editing Market Overview
  • 23.2. North America Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gene Editing Market

  • 24.1. USA Gene Editing Market Overview
  • 24.2. USA Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gene Editing Market

  • 25.1. Canada Gene Editing Market Overview
  • 25.2. Canada Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gene Editing Market

  • 26.1. South America Gene Editing Market Overview
  • 26.2. South America Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gene Editing Market

  • 27.1. Brazil Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gene Editing Market

  • 28.1. Middle East Gene Editing Market Overview
  • 28.2. Middle East Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gene Editing Market

  • 29.1. Africa Gene Editing Market Overview
  • 29.2. Africa Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gene Editing Market Competitive Landscape And Company Profiles

  • 30.1. Gene Editing Market Competitive Landscape
  • 30.2. Gene Editing Market Company Profiles
    • 30.2.1. AstraZeneca plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE Healthcare Life Sciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Gene Editing Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. PerkinElmer Inc.
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Qiagen N.V.
  • 31.5. CRISPR Therapeutics
  • 31.6. Sigma-Aldrich Corporation
  • 31.7. Promega Corporation
  • 31.8. GenScript USA Inc.
  • 31.9. Integrated DNA Technologies Inc.
  • 31.10. Intellia Therapeutics Inc.
  • 31.11. DNA Script Inc.
  • 31.12. Juno Therapeutics Inc.
  • 31.13. Dharmacon Inc.
  • 31.14. Precision Biosciences Inc.
  • 31.15. Editas Medicine Inc.

32. Global Gene Editing Market Competitive Benchmarking

33. Global Gene Editing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gene Editing Market

35. Gene Editing Market Future Outlook and Potential Analysis

  • 35.1 Gene Editing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Gene Editing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Gene Editing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer